デュオカルミシンとCC-1065の類似体のユニークなクラスで,還元活性化により活性化されます
Wei Jin1, John D Trzupek, Thomas J Rayl
1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Journal of the American Chemical Society
|November 21, 2007
まとめ
新しい抗腫瘍前薬は,ヒポキシ性腫瘍で活性化され,有効な薬物を効果的に放出します. これらの新薬は活体内で強力で強化された有効性を示し,標的がん治療の利点を提供します.
科学分野:
- 薬用化学 薬用化学について
- がん薬理学 がん薬理学
- ドラッグ開発 ドラッグ開発
背景:
- デオカルミシンとCC-1065は強力な抗腫瘍剤である.
- 低毒性腫瘍環境は,より高い減少能力を持っています.
- 還元活性化は,標的の薬物投与のための戦略を提供します.
研究 の 目的:
- デオカルミシンとCC-1065.5の新たな還元活性化前薬の開発と特徴づけ
- これらの前薬剤の安定性と放出運動性を評価する.
- プロドラッグの in vitro および in vivo の有効性を評価する.
主な方法:
- N-アシルO-アミノフェノール誘導体の合成.
- 癌細胞系における in vitro 細胞毒性アッセイ.
- In vitro DNAアルキレーションと安定性に関する研究.
- 動物モデルでのin vivo有効性研究.
主要な成果:
- プロドラッグは,細胞アッセイで有効な薬物放出と細胞毒性活性を示した.
- プロドラッグは,生理学的条件下でインビトロで安定性を示した.
- In vivo試験では,前薬がフリー薬の効能に匹敵し,またはそれを上回ったことが示されました.
結論:
- N-アシルO-アミノフェノール誘導体は,新種の還元活性化前薬である.
- これらの前薬は,より高い有効性を持つ標的がん治療の可能性を秘めています.
- プロドラッグは,in vivoアプリケーションにおいて,好ましい安定性と放出プロファイルを示しています.
関連する概念動画
Cycloaddition Reactions: MO Requirements for Photochemical Activation
Some cycloaddition reactions are activated by heat, while others are initiated by light. For example, a [2 + 2] cycloaddition between two ethylene molecules occurs only in the presence of light. It is photochemically allowed but thermally forbidden.
Photochemical Electrocyclic Reactions: Stereochemistry
The absorption of UV–visible light by conjugated systems causes the promotion of an electron from the ground state to the excited state. Consequently, photochemical electrocyclic reactions proceed via the excited-state HOMO rather than the ground-state HOMO. Since the ground- and excited-state HOMOs have different symmetries, the stereochemical outcome of electrocyclic reactions depends on the mode of activation; i.e., thermal or photochemical.
Selection Rules: Photochemical Activation
Selection Rules: Photochemical Activation
Cycloaddition Reactions: MO Requirements for Thermal Activation
Thermal cycloadditions are reactions where the source of activation energy needed to initiate the reaction is provided in the form of heat. A typical example of a thermally-allowed cycloaddition is the Diels–Alder reaction, which is a [4 + 2] cycloaddition. In contrast, a [2 + 2] cycloaddition is thermally forbidden.
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for the...
Cycloaddition Reactions: Overview
Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.

![[(DPEPhos)(bcp)Cu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59739.jpg&w=3840&q=50)
